lobbying_activities: 2606997

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2606997	d15da7c4-ebb3-4d4c-abbe-e4dca3a47a82	Q1	THE RABEN GROUP	61458	BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND)	2021	first_quarter	CHM	Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act; Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act. Funding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill.	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2021-04-19T19:29:05.473000-04:00